Chiral Technology International Technology Market Trends

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Key Pharma News 15 DECEMBER 2014

Key Pharma News 15 DECEMBER 2014

  • $ 1 415
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 29 pages

Industry Trend Analysis - Merck Claims Leadership Of Revived Antibiotics Market With Cubist Acquisition Industry Trend Analysis - Pfizer Will Become Serious Contender In Immuno-Oncology Industry Brief - UCB/Daiichi Sankyo To Jointly Commercialise Lacosamide In Japan Industry Brief - Evotec/Sanofi In ...

Industries: Drug and Medication | Countries: South Korea, United States, Japan, World, Canada, Italy, China, Europe

Anti-Infective Drug News 08 DECEMBER 2014

Anti-Infective Drug News 08 DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 16 pages

Industry Trend Analysis - Drugmakers Undertake Risks To Enable Ebola Vaccines To Reach Market Faster Industry Brief - FDA Approves Onexton Gel For Acne Vulgaris Industry Brief - Dificlir Proven To Be Clinically/Cost Effective Over SoC Treatments In CDI Industry Brief - Basilea Launches Zevtera In Germany ...

Industries: Drug and Medication | Countries: Italy, Germany, Europe

Turkey Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Turkey Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • December 2014
  • 125 pages

BMI View: Turkey's pharmaceutical industry offers strong growth potential and will continue to be viewed as an attractive industry for foreign drugmakers, particularly those who are interested in the take over of the remaining (mainly private) domestic producers. However, when compared with other majo ...

Industries: Drug and Medication | Countries: Turkey, Europe, United States

Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

  • $ 3 900
  • Industry report
  • by Firstword Pharma
  • December 2014

As the cancer drug market continues to face significant challenges in an environment of rising R&D costs, value-based pricing, demands for real world evidence and tougher regulation, the role of Medical Affairs teams in oncology working across the major markets of Europe - France, Germany, Italy, Spain ...

Industries: Pathology | Countries: Europe

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • December 2014
  • 48 pages

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 Summary Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the body's immune system attacks the lining of the joints causing an inflammatory response. RA is characterized by joint swelling, ...

Industries: Pathology | Countries: Japan, India, China, World, Australia, Spain, Italy, France, Germany, United States, United Kingdom, Europe

Key Pharma News 01 DECEMBER 2014

Key Pharma News 01 DECEMBER 2014

  • $ 1 415
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 32 pages

Industry Trend Analysis - Merck KGaA/Pfizer Alliance Is Strategic Move For Both In Immuno-Oncology Industry Trend Analysis - CAR-T Therapy Arena Heats Up With Another Biotech Collaboration Industry Trend Analysis - Continued Focus On European Generics Sales Important For STADA Industry Trend Analysis ...

Industries: Pathology | Countries: Japan, Brazil, Russian Federation, Europe, World, United States

Autoimmune Drug Focus NOVEMBER 2014

Autoimmune Drug Focus NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 20 pages

Industry Trend Analysis - BMS Interest Underlines Vitality Of Underserved IPF Market Industry Brief - Novo Nordisk Invests In New Danish Laboratory Facility Industry Brief - BI/Lilly Revise Operational Structure Of Diabetes Alliance Industry Brief - Paediatric Type I Diabetes Diamyd/GABA Combination ...

Industries: Drug and Medication | Countries: Europe, Canada, World, United Kingdom, Sweden, Germany, Denmark, Japan, United States

World Generic Markets 24 NOVEMBER 2014

World Generic Markets 24 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 16 pages

Industry Trend Analysis - Acquisition Of Allergan Will Transform Actavis Industry Brief - Teva Launches Celecoxib In Canada Industry Brief - Beximco Gains Canadian GMP Approval Industry Brief - FDA Rescinds Ranbaxy Exclusivities Creating Opportunity For Dr Reddy's And Endo Industry Brief - Sucampo Files ...

Industries: Drug and Medication | Countries: World, Canada, United States, United Kingdom, Switzerland, Europe, Saudi Arabia, North America

C-Rad AB (Symbol:CRAD B) SWOT Analysis, Strategy, Revenues and Profits

C-Rad AB (Symbol:CRAD B) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. C-Rad AB SWOT Analysis report provides you a strategic analysis and ...

Industries: Therapy | Countries: China, Netherlands, Sweden, Spain, Poland, Greece, France, Belgium, Austria, Thailand, Taiwan, South Korea, India, Europe

APOGEPHA Arzneimittel GmbH SWOT Analysis, Strategy, Revenues and Profits

APOGEPHA Arzneimittel GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: Slovenia, Portugal, Italy, Ireland, Greece, Germany, Croatia, Belgium, Europe

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.